Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB 1) receptors are potent analgesics devoid of tolerance

Morgan Le Naour, Eyup Akgün, Ajay Yekkirala, Mary M. Lunzer, Mike D. Powers, Alexander E. Kalyuzhny, Philip S. Portoghese

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB 1) receptors are potent analgesics devoid of tolerance'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds